116 related articles for article (PubMed ID: 30218755)
1. Overexpression of ADAMTS-2 in tumor cells and stroma is predictive of poor clinical prognosis in gastric cancer.
Jiang C; Zhou Y; Huang Y; Wang Y; Wang W; Kuai X
Hum Pathol; 2019 Feb; 84():44-51. PubMed ID: 30218755
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
3. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J
Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443
[TBL] [Abstract][Full Text] [Related]
4. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
5. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of aberrant G protein-couple receptor 110 (GPR110) expression in gastric cancer.
Zhu X; Huang G; Jin P
Pathol Res Pract; 2019 Mar; 215(3):539-545. PubMed ID: 30638950
[TBL] [Abstract][Full Text] [Related]
7. ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.
Zhang M; Zhang C; Du W; Yang X; Chen Z
Clin Transl Oncol; 2016 Aug; 18(8):776-81. PubMed ID: 26527032
[TBL] [Abstract][Full Text] [Related]
8. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
9. CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Zhang XG; Song BT; Liu FJ; Sun D; Wang KX; Qu H
Clin Transl Oncol; 2016 Jul; 18(7):700-7. PubMed ID: 26489425
[TBL] [Abstract][Full Text] [Related]
10. MET is overexpressed in microsatellite instability-high gastric carcinoma.
Sim J; Heo YJ; Bae H; Shin HC; Kim B; Cho J; Kim ST; Lee J; Kang WK; Kim KM
Pathol Res Pract; 2019 Mar; 215(3):433-438. PubMed ID: 30455128
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY
Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801
[TBL] [Abstract][Full Text] [Related]
12. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
[TBL] [Abstract][Full Text] [Related]
13. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.
Ye F; Jin P; Cai X; Cai P; Cai H
Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314
[TBL] [Abstract][Full Text] [Related]
14. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.
Jin C; Lin JR; Ma L; Song Y; Shi YX; Jiang P; Dong Y; Li XS
Oncotarget; 2017 Feb; 8(6):10416-10424. PubMed ID: 28060752
[TBL] [Abstract][Full Text] [Related]
15. Low expression of PDHA1 predicts poor prognosis in gastric cancer.
Song L; Liu D; Zhang X; Zhu X; Lu X; Huang J; Yang L; Wu Y
Pathol Res Pract; 2019 Mar; 215(3):478-482. PubMed ID: 30611622
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients.
Wang Z; Liu H; Shen Z; Wang X; Zhang H; Qin J; Xu J; Sun Y; Qin X
BMC Cancer; 2015 Oct; 15():766. PubMed ID: 26497045
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.
Zhao J; Mai C; Weng D; Chen C; Zhou Z; Liu Y; Zhou Z; Wang P
Cancer Biomark; 2018; 22(3):375-384. PubMed ID: 29758923
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
